从史诗般的电子医疗记录中确定吸入性皮质类固醇的坚持
Ashley Galbreath1, Anzeela Schentrup1,2, Sreekala Prabhakaran3
1College of Pharmacy (AG, LH, AS), University of Florida Physicians (AS), and.
概括
这是一个史诗般的史诗.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 评估患者对吸入性皮质类固醇 (ICS) 治疗的坚持对于管理严重喘至关重要.
- 药房补充历史记录通常用于估计ICS遵守.
- 像Epic这样的电子健康记录 (EHR) 系统可能为访问补充数据提供了一个方便的替代方案.
研究的目的:
- 为了评估吸入性皮质类固醇 (ICS) 和ICS/长效β-激动剂 (LABA) 组合的补充史的准确性,如Epic的药物处置史中记录的.
- 为了比较Epic的补充数据与实际药房补充记录的准确性.
主要方法:
- 对38名患有严重喘的儿科患者进行了回顾性审查.
- 患者符合特定的标准:相同的ICS产品/剂量6个月和可用的药房数据.
- 药房补充记录是口头获得的,并使用威尔科克森匹配对签名等级测试与Epic的发放药物历史进行了比较.
主要成果:
- 由于重复的条目,Epic的初始补充数据含有54%的错误率.
- 在重复删除后,Epic的平均补充数 (3.6) 略高于药房记录 (3.3) (p < 0.0001).
- 史诗精确地报告了78.9%的患者的总补充量;然而,在个人补充计数中注意到了差异.
结论:
- 目前的Epic版本过度报告ICS补充,可能会阻碍准确的遵守评估.
- 在Epic中缺少补充似乎是一个可靠的指标,表明其坚持不良.
- 临床依赖Epic的补充史来监测坚持需要仔细考虑,因为过度报告的趋势.
相关概念视频
01:23Inhaled Medications
261
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
01:26COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:30Methods of Documentation VII: EMR
835
Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare...
835
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K